Ozempic is FDA-approved for: Controlling blood sugar in adults with type 2 diabetes Reducing the risk of serious heart problems, like heart attack, stroke, and death, in adults with type 2 diabetes and heart disease Reducing the risk of worsening kidney disease and cardiovascular deaths in adults with type 2 diabetes and chronic kidney disease Although Ozempic isnt FDA-approved for weight loss, a healthcare provider may prescribe it off-label to help with weight management
For more information, please visit www.ascletis.com
Overall, tirzepatide reduced the AHI, body weight, hypoxic burden, high-sensitivity C-reactive protein concentration, and systolic blood pressure, and it improved sleep-related patient-reported outcomes
Capasso L, De Masi L, Sirignano C, Maresca V, Basile A, Nebbioso A, et al